comprehensive -WSS

comprehensive

author：explore 2025-09-28 02:30:57 - browse：9144

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： First U.S. drug developed to treat liver disease MASH is approved

WSS

European officials brace for rough respiratory virus season

First U.S. drug developed to treat liver disease MASH is approved

Boston's new lab space is opening empty

CDC picks Alphabet's Verily for wasterwater surveillance contract

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

FDA advisers back CAR

explore

comprehensive

focus

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Guidelines to prevent youth baseball injuries need more muscle

President Biden's budget: Here's what you might have missed

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Setback for rare diseases as Taysha Gene Therapies pulls back

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: CAR

Affirmative action in medical school literally saved lives

2023 Nobel Prize in Medicine goes to Karikó and Weissman

explore

Boston's new lab space is opening empty

How many hemophilia patients actually want gene therapy?

With Roe v Wade overturned, abortion providers work to adapt

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Health insurers' Q3 question: how much care are people getting?

Flu, Covid vaccination rates decline, new survey data show

entertainment

focus

leisure time

leisure time